We are live on ! Find out more
Ensign Peak Advisors

Ensign Peak Advisors Portfolio holdings

AUM $53.7B
1-Year Est. Return 29.47%
This Fund
S&P 500
This Quarter Est. Return
+13.33%
1 Year Est. Return
+29.47%
3 Year Est. Return
+102.45%
5 Year Est. Return
+139.11%
10 Year Est. Return
AUM
$54.8B
AUM Growth
+$4.24B
Cap. Flow
-$502M
Cap. Flow %
-0.92%
Top 10 Hldgs %
29.94%
Holding
1,776
New
37
Increased
449
Reduced
1,142
Closed
51

Top Buys

Rank Stock Value
1
LLY icon
Eli Lilly
LLY
+$158M
2
UBER icon
Uber
UBER
+$110M
3
BXSL icon
Blackstone Secured Lending
BXSL
+$97.3M
4
AMZN icon
Amazon
AMZN
+$76.3M
5
PYPL icon
PayPal
PYPL
+$75.8M

Top Sells

Rank Stock Value
1
VRTX icon
Vertex Pharmaceuticals
VRTX
+$184M
2
CCI icon
Crown Castle
CCI
+$173M
3
CME icon
CME Group
CME
+$125M
4
GILD icon
Gilead Sciences
GILD
+$119M
5
AMGN icon
Amgen
AMGN
+$115M

Sector Composition

Rank Sector Weight
1 Technology 28.81%
2 Healthcare 15.16%
3 Financials 13.11%
4 Consumer Discretionary 9.82%
5 Communication Services 8.19%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
VRDN icon
1751
Viridian Therapeutics
VRDN
$2.18B
-89,185
Closed -$1.94M
VTYX
1752
DELISTED
Ventyx Biosciences
VTYX
-101,175
Closed -$250K
X
1753
DELISTED
US Steel
X
-84,235
Closed -$4.1M
XLB icon
1754
State Street Materials Select Sector SPDR ETF
XLB
$8.66B
-16,468
Closed -$704K
XLI icon
1755
State Street Industrial Select Sector SPDR ETF
XLI
$33.4B
-4,022
Closed -$458K
ZNTL icon
1756
Zentalis Pharmaceuticals
ZNTL
$321M
-194,933
Closed -$2.95M
NBIS
1757
Nebius Group N.V.
NBIS
$47.7B
$0 ﹤0.01%
22,300
CTLT
1758
DELISTED
CATALENT, INC.
CTLT
-63,160
Closed -$2.84M
AXNX
1759
DELISTED
Axonics, Inc. Common Stock
AXNX
-20,850
Closed -$1.3M
SWN
1760
DELISTED
Southwestern Energy Company
SWN
-309,240
Closed -$2.03M
CERE
1761
DELISTED
Cerevel Therapeutics Holdings, Inc. Common Stock
CERE
-66,655
Closed -$2.83M
ETRN
1762
DELISTED
Equitrans Midstream Corporation Common Stock
ETRN
-166,640
Closed -$1.7M
KAMN
1763
DELISTED
Kaman Corp
KAMN
-31,495
Closed -$754K
CPE
1764
DELISTED
Callon Petroleum Company
CPE
-22,970
Closed -$744K
PGTI
1765
DELISTED
PGT, Inc.
PGTI
-31,247
Closed -$1.27M
CBAY
1766
DELISTED
Cymabay Therapeutics
CBAY
-46,700
Closed -$1.1M
AYX
1767
DELISTED
Alteryx Inc
AYX
-22,510
Closed -$1.06M
BCEL
1768
DELISTED
Atreca, Inc. Class A Common Stock
BCEL
-105,283
Closed -$13.9K
KRTX
1769
DELISTED
Karuna Therapeutics, Inc. Common Stock
KRTX
-146,467
Closed -$46.4M
MDRX
1770
DELISTED
Veradigm Inc. Common Stock
MDRX
-44,050
Closed -$462K
ROVR
1771
DELISTED
Rover Group, Inc. Class A Common Stock
ROVR
-216,051
Closed -$2.35M
THRX
1772
DELISTED
Theseus Pharmaceuticals, Inc. Common Stock
THRX
-139,196
Closed -$564K
LTHM
1773
DELISTED
Livent Corporation
LTHM
-139,897
Closed -$2.52M
RPT
1774
DELISTED
RPT Realty Common Shares of Beneficial Interest (MD)
RPT
-57,900
Closed -$743K
LBPH
1775
DELISTED
Longboard Pharmaceuticals, Inc. Common Stock
LBPH
-301,161
Closed -$1.82M

Similar funds

Ensign Peak Advisors's Q1 2024 Portfolio in Review

As of Q1 2024, Ensign Peak Advisors held 1,776 positions worth $54.8B, up 8.4% from $50.5B the previous quarter. Its ten largest holdings account for 30% of the portfolio.

Trading was light in Q1 2024: portfolio turnover was 5%. Ensign Peak Advisors opened 37 new positions and exited 51, leaving the 1,776-position portfolio largely intact.

By sector, the portfolio is most concentrated in Technology at 29% of assets, up from 27% a quarter earlier, followed by Healthcare and Financials.

  • Ensign Peak Advisors's largest Q1 2024 buy was Blackstone Secured Lending: 3,319,725 shares worth $103M.
  • Ensign Peak Advisors added most to Eli Lilly in Q1 2024, an estimated $158M increase.
  • Ensign Peak Advisors's biggest Q1 2024 reduction was Vertex Pharmaceuticals, cutting an estimated $184M.
  • Ensign Peak Advisors fully exited State Street SPDR S&P 500 ETF Trust in Q1 2024, selling an estimated $66.5M.
  • Ensign Peak Advisors's ten largest holdings make up 30% of its $54.8B portfolio in Q1 2024.
  • Ensign Peak Advisors opened 37 new positions and closed 51 in Q1 2024.
  • Ensign Peak Advisors's portfolio value rose 8.4% quarter-over-quarter to $54.8B.

Based on Ensign Peak Advisors's 13F filing for Q1 2024, filed 14 May 2024.